SMMNY Siemens Healthineers Adrs

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and distributes imaging, diagnostic, and advanced therapies products and services to healthcare providers worldwide. The company operates through three segments; Imaging, Diagnostics, and Advanced Therapies. The Imaging segment offers magnetic resonance, computed tomography, X-ray, molecular imaging, and ultrasound systems. The Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in laboratory, molecular, and point-of-care diagnostics; and workflow solutions and informatics products. The Advanced Therapies segment offers integrated products, solutions, and services for therapy departments of healthcare providers; and robotic-assisted platform for endo-vascular coronary and peripheral vascular interventions. This segment's principal products include angiography systems and mobile C-arms. It also provides customer value chain services, including design, maintenance, operational management, training, and education services. In addition, the company offers equipment performance management, clinical education and e-learning, asset management, and managed departmental services, as well as digital health products and services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft. This is an ADR of a company whose stock trades outside of the U.S. as the symbol GY:SHL.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$33.18    Pink
As of 01/18/2022     OTCMarkets


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Large cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  Germany
Country of incorporation:  Germany
IPO date:  11/21/2018
Outstanding shares:  2,256,000,000
Average volume:  38,640
Market cap:   $76,771,905,600
Current dividend yield:  1.41%
Sedol:      
Valuation   (See tab for details)
PE ratio:   44.45
PB ratio:   4.68
PS ratio:   4.27
Return on equity:   10.58%
Net income %:   9.60%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy